BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 25569804)

  • 1. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
    Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
    Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway.
    Guo J; Guo Q; Fang H; Lei L; Zhang T; Zhao J; Peng S
    Eur J Pharmacol; 2014 Aug; 737():117-24. PubMed ID: 24858368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
    Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
    Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy.
    Akolkar G; da Silva Dias D; Ayyappan P; Bagchi AK; Jassal DS; Salemi VMC; Irigoyen MC; De Angelis K; Singal PK
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H795-H809. PubMed ID: 28710069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.
    Pacher P; Liaudet L; Bai P; Mabley JG; Kaminski PM; Virág L; Deb A; Szabó E; Ungvári Z; Wolin MS; Groves JT; Szabó C
    Circulation; 2003 Feb; 107(6):896-904. PubMed ID: 12591762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment.
    Guo Q; Guo J; Yang R; Peng H; Zhao J; Li L; Peng S
    Oxid Med Cell Longev; 2015; 2015():151972. PubMed ID: 26075032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
    Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
    Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagic dysregulation in doxorubicin cardiomyopathy.
    Bartlett JJ; Trivedi PC; Pulinilkunnil T
    J Mol Cell Cardiol; 2017 Mar; 104():1-8. PubMed ID: 28108310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
    Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
    J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
    Yu X; Cui L; Zhang Z; Zhao Q; Li S
    Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane protects the heart from doxorubicin-induced toxicity.
    Singh P; Sharma R; McElhanon K; Allen CD; Megyesi JK; Beneš H; Singh SP
    Free Radic Biol Med; 2015 Sep; 86():90-101. PubMed ID: 26025579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
    Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
    Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of troxerutin on oxidative stress and expression of genes regulating mitochondrial biogenesis in doxorubicin-induced myocardial injury in rats.
    Babaei-Kouchaki S; Babapour V; Panahi N; Badalzadeh R
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1187-1195. PubMed ID: 31960154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
    Rajesh M; Mukhopadhyay P; Bátkai S; Patel V; Saito K; Matsumoto S; Kashiwaya Y; Horváth B; Mukhopadhyay B; Becker L; Haskó G; Liaudet L; Wink DA; Veves A; Mechoulam R; Pacher P
    J Am Coll Cardiol; 2010 Dec; 56(25):2115-25. PubMed ID: 21144973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.
    Pacher P; Liaudet L; Bai P; Virag L; Mabley JG; Haskó G; Szabó C
    J Pharmacol Exp Ther; 2002 Mar; 300(3):862-7. PubMed ID: 11861791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.